NEWARK, Del, Nov. 19, 2023 (GLOBE NEWSWIRE) -- Future Market Insights’ latest industry analysis shows that the global cosmetic CDMO market was valued at around US$ 21,230.4 million in 2022. The market is further anticipated to exhibit a CAGR of 5.8% over the forecast period (2024 to 2034).
Cosmetic CDMOs are valuable partners for cosmetic brands, helping them bring products to market efficiently and cost-effectively while ensuring product quality and regulatory compliance. Their expertise and resources enable brands to focus on marketing, distribution, and other aspects of their business, while the CDMOs handle the technical and manufacturing aspects of cosmetic production.
Request Your Sample Report for more insights into the Cosmetic CDMO Market:
Consumers have diverse skin types, concerns, and preferences. Brands seek CDMOs that can create unique formulations tailored to specific customer segments, allowing them to address a broader market. Brands would want to offer product variations to cater to customer needs, such as multiple shades of foundation or skincare products.
Brands aim to stand out by offering customized or personalized products. CDMOs help brands differentiate themselves from competitors by providing customization capabilities.
Personalized products can foster brand loyalty, as consumers appreciate products uniquely tailored to their preferences. Brands seek CDMOs to create these loyalty-building experiences.
Brands are introducing innovative ingredients and benefits in their products. CDMOs can be pivotal in formulating and producing these unique and innovative cosmetic products.
In addition, personalization trends often drive the need for adaptive formulations that adjust to individual skin types and concerns. CDMOs work on developing new formulations that can be adjusted according to customer needs.
Key Takeaways from the Cosmetic CDMO Industry Study:
- By service, the contract manufacturing segment will display a CAGR of 5.5% over the forecast period.
- By product type, the skin products segment is set to witness a lucrative CAGR of 4.9% through 2034.
- By form, the cream segment held the leading share of 32.9% in 2022.
- East Asia is considered the leading region, with a value share of 22.7% at the end of the forecast period.
- The cosmetic CDMO market is anticipated to exhibit a CAGR of 5.8% by 2034.
“Continuous skin care and cosmetics innovation needs CDMO expertise, driving the market. Rising demand for CDMOs is driven by the requirement to follow stringent safety and cosmetic norms,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Request Methodology Now! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-18278
Competitive Landscape in the Cosmetic CDMO Market:
Acquisitions and agreements among leading companies are the key strategies of renowned manufacturers in the market, such as PARAGON NORDIC and Kolmar, among others. They aim to enhance their presence in the market and compete with other players.
Following are a few examples of acquisitions made by them to be at the top position:
- In July 2021, Process Technologies & Packaging was fully acquired by Kolmar Korea Co LTD affiliate SEOKOH, Inc.
- Kolmask, a division of Kolmar Korea Holdings, purchased Jayjun Cosmetic's sheet mask production facility in Incheon in July 2019, increasing the company's ability to produce sheet masks and providing it with access to Jayjun's Chinese distribution network.
Key Companies Profiled in the Cosmetic CDMO Industry:
- Teleflex Incorporated
- Swiss American CDMO
- Pierre Fabre Group
- Zymo Cosmetics
- Fareva
- Biopharma Srl C.F.
- Chemineau
- Cosmetic Solutions
- PARAGON NORDIC
- C.O.C. Farmaceutici Srl
- Kolmar [Kolmar Korea Holding]
- Lonza (Global)
- Cho Chuang Industrial Co., Ltd. [Mailkang Cosmetics Co., Ltd.]
- Vive Cosmetics
- Ori BioNature Sdn Bhd
- Zoic Cosmetic
- Samriddhi Life Sciences
- Natrocare
Click Here To Buy Your Full Report: https://www.futuremarketinsights.com/checkout/18278
Key Segments Covered in Cosmetic CDMO Market Report:
By Service:
- Contract Development
- Formulation Development
- Pilot Studies
- Contract Manufacturing
- Bulk Preparation and Scale Up
- Safety Testing
- Filling and Packaging
- Close Jars
- Bottles
- Tubes
- Roll-ons
- Others
By Product Type:
- Hair Products
- Skin Products
- Lip Products
- Eye Products
- Body Hygiene
- Oral Hygiene
- Others
By Form:
- Solid Form and Powder
- Lotions
- Creams
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
About the Healthcare Division at Future Market Insights (FMI)
Future Market Insights (FMI) facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business.
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at Related Reports Covered in the Cosmetic CDMO Market:
- Cosmetic Surgery Products Market is projected to reach US$ 19.09 billion in 2023. Over the forecast period from 2023 to 2033, it is anticipated to demonstrate a CAGR of 8.1%, resulting in a total accumulation of US$ 41.64 billion by 2033.
- Ultra-fine Medical Wire Market size was valued at US$ 237.9 million in 2022 and is expected to reach US$ 466.2 million by 2033. It is set to rise at a CAGR of close to 6.4% over the forecast period (2023 to 2033).
- Antacids Market is expected to be worth US$ 6,971.2 million by the end of 2023 and further expand at a CAGR of 4.9% to reach a valuation of US$ 11,194.8 million by 2033.
- Veterinary Ultrasound Scanner Market is set for significant expansion, with an anticipated valuation of US$ 198.1 million by 2023. The market displays a significant trend, featuring a CAGR of 3.7%, expected to endure until 2033.
- Anti-hangover Supplement Market is expected to record a valuation of US$ 1.9 billion by the end of 2023 and further expand at a remarkable CAGR of 14.5% to reach a valuation of US$ 6.8 billion by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
